Cryo Cell International (CCEL) Treasury Shares (2010 - 2026)

Cryo Cell International has disclosed Treasury Shares across 17 years of filings, most recently posting $25.0 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 0.68% year-over-year to $25.0 million; the TTM figure through Feb 2026 stood at $25.0 million (up 0.68% YoY), while the FY2025 annual figure was $25.0 million, up 0.68% from the prior year.
• Treasury Shares held at $25.0 million in Q1 2026, from $25.0 million in the prior quarter.
• Over the last five years, Treasury Shares for CCEL reached as high as $6.8 million in Q3 2025 and fell as low as $31808.0 in Q1 2024.
• The 5-year median for Treasury Shares is $223999.0 (2024), against an average of $3.0 million.
• Annual changes were most pronounced in 2022 — Treasury Shares gained 9.44% — and 2025, when it increased 0.42%.
• A 5-year view of Treasury Shares shows it stood at $22.6 million in 2022, then increased by 3.53% to $23.4 million in 2023, then climbed by 6.08% to $24.9 million in 2024, then gained by 0.68% to $25.0 million in 2025, then changed by 0.0% to $25.0 million in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $25.0 million, $25.0 million, and $25.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.